Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioRestorative Therapies, Inc.BRTX · Entity 8277 | 10% owner | October 28, 2024 | November 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioRestorative Therapies, Inc.
Report date October 28, 2024 · Filed November 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 445,933 |
Reported balance
After 2024-10-28 transaction · row 1
1 source rowRow 1 · 2024-10-28 · Sale · Disposed 1,112 · Balance 445,933 |
| Common StockSEC Table I · non-derivative | IndirectSee Fotenote | 477,972 |
Reported balance
Holding disclosure · report date 2024-10-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 477,972 F1: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Filing footnotes · ownership attribution and instrument terms
F1: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2024 Filed Nov 5, 2024 21:33 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | SaleCommon Stock | 1,112 | $1.58 | $1,756.96 |
DisclosureSEC source: 0001021771-24-000184 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,933 Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 14:26 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 86,041 | $1.32 | $113,574.12 |
DisclosureSEC source: 0001021771-24-000038 · form4.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 477,972 F1 · ownership.nature: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 13:00 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 83,626 | $1.34 | $112,058.84 |
DisclosureSEC source: 0001021771-24-000035 · form4.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,045 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 14:26 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 73,959 | $1.25 | $92,448.75 |
DisclosureSEC source: 0001021771-24-000038 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Ssee Footnote Disclosed balance after: 391,931 F1 · ownership.nature: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 13:00 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 36,374 | $1.38 | $50,196.12 |
DisclosureSEC source: 0001021771-24-000035 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,419 Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:32 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | SaleCommon Stock | 250 | $1.88 | $469.25 |
DisclosureSEC source: 0001021771-23-000118 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,045 Read SEC document |
| November 27, 2023 Filed Dec 1, 2023 22:04 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | SaleCommon Stock | 278 | $1.89 | $525.42 |
DisclosureSEC source: 0001021771-23-000116 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,295 Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 13:20 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 10,000 | $1.66 | $16,600.00 |
DisclosureSEC source: 0001021771-23-000098 · form4.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,573 Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 13:20 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 10,000 | $1.54 | $15,400.00 |
DisclosureSEC source: 0001021771-23-000098 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,573 Read SEC document |
| September 07, 2023 Filed Sep 14, 2023 20:08 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $1.91 | $1,910.00 |
DisclosureSEC source: 0001021771-23-000092 · form4.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 317,972 F1 · ownership.nature: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. Read SEC document |
| September 07, 2023 Filed Sep 14, 2023 20:08 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $1.81 | $1,810.00 |
DisclosureSEC source: 0001021771-23-000092 · form4.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,573 Read SEC document |
| July 28, 2023 Filed Sep 14, 2023 20:08 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 500 | $2.89 | $1,445.00 |
DisclosureSEC source: 0001021771-23-000092 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,573 Read SEC document |
| July 27, 2023 Filed Jul 28, 2023 15:17 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $2.80 | $2,800.00 |
DisclosureSEC source: 0001140361-23-036665 · form4.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,073 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.75 to $2.85 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: The reporting person also owns 316,972 shares indirectly through Fleetco, Inc. of which the reporting person is a 93% shareholder. Read SEC document |
| February 22, 2023 Filed Mar 3, 2023 21:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $2.95 | $2,950.00 |
DisclosureSEC source: 0001567619-23-004348 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,073 Read SEC document |
| February 22, 2023 Filed Mar 3, 2023 21:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 5,000 | $2.84 | $14,200.00 |
DisclosureSEC source: 0001567619-23-004348 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,073 Read SEC document |
| November 30, 2022 Filed Mar 3, 2023 21:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 100 | $2.77 | $277.00 |
DisclosureSEC source: 0001567619-23-004348 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,073 Read SEC document |
| November 30, 2022 Filed Mar 3, 2023 21:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 100 | $2.78 | $278.00 |
DisclosureSEC source: 0001567619-23-004348 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,973 Read SEC document |
| September 23, 2022 Filed Sep 27, 2022 21:23 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 300 | $2.83 | $848.97 |
DisclosureSEC source: 0001567619-22-017856 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,873 Read SEC document |
| July 13, 2022 Filed Jul 15, 2022 15:46 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 200 | $3.00 | $600.00 |
DisclosureSEC source: 0001567619-22-014051 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,573 Read SEC document |
| July 12, 2022 Filed Jul 15, 2022 15:46 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 900 | $2.97 | $2,673.00 |
DisclosureSEC source: 0001567619-22-014051 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,373 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.95 to $2.9799 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| July 06, 2022 Filed Jul 15, 2022 15:46 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 100 | $3.38 | $337.99 |
DisclosureSEC source: 0001567619-22-014051 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,473 Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:10 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,900 | $3.08 | $5,849.91 |
DisclosureSEC source: 0001567619-22-013688 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,373 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.00 to $3.1499 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 19:42 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 100 | $3.68 | $367.96 |
DisclosureSEC source: 0001567619-22-013309 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,473 Read SEC document |
| June 17, 2022 Filed Jun 23, 2022 19:42 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 600 | $3.80 | $2,281.98 |
DisclosureSEC source: 0001567619-22-013309 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,373 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.69 to $3.9375 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:05 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 2,000 | $3.81 | $7,611.00 |
DisclosureSEC source: 0001567619-22-013111 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,773 F2 · price: This transaction was executed in multiple trades at prices ranging from $3.5718 to $3.8999 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:05 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,200 | $3.72 | $4,463.88 |
DisclosureSEC source: 0001567619-22-013111 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,773 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.65 to $3.7799 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:45 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,300 | $3.92 | $5,096.52 |
DisclosureSEC source: 0001567619-22-012901 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,573 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.8999 to $4.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 19:33 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 600 | $4.23 | $2,539.98 |
DisclosureSEC source: 0001567619-22-012747 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,273 F2 · price: This transaction was executed in multiple trades at prices ranging from $4.1899 to $4.2999 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 19:33 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $4.27 | $4,265.70 |
DisclosureSEC source: 0001567619-22-012747 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,673 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.17 to $4.3699 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:42 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 2,400 | $4.33 | $10,395.12 |
DisclosureSEC source: 0001567619-22-012605 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,673 F2 · price: This transaction was executed in multiple trades at prices ranging from $4.1999 to $4.6199 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:42 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,600 | $4.72 | $17,003.16 |
DisclosureSEC source: 0001567619-22-012605 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,273 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.585 to $4.7699 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 17:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $4.93 | $14,797.50 |
DisclosureSEC source: 0001567619-22-012430 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,673 F2 · price: This transaction was executed in multiple trades at prices ranging from $4.8531 to $4.9676 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 17:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,200 | $4.90 | $5,879.28 |
DisclosureSEC source: 0001567619-22-012430 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,673 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.80 to $4.9199 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:35 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $4.69 | $4,687.80 |
DisclosureSEC source: 0001567619-22-012367 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.48 to $4.8943 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:03 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 9,213 | $4.46 | $41,122.23 |
DisclosureSEC source: 0001567619-22-012250 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.0659 to $4.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 10,957 | $3.61 | $39,592.02 |
DisclosureSEC source: 0001567619-22-012010 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,260 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.3499 to $3.7999 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:18 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | SaleCommon Stock | 2,000 | $3.44 | $6,875.60 |
DisclosureSEC source: 0001567619-22-011949 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,303 F2 · price: This transaction was executed in multiple trades at prices ranging from $3.39 to $3.465 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:18 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 4,950 | $3.51 | $17,364.11 |
DisclosureSEC source: 0001567619-22-011949 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,303 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.4787 to $3.5599 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:23 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 2,500 | $5.66 | $14,150.00 |
DisclosureSEC source: 0001567619-22-008301 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,353 Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:15 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 30,000 | $5.64 | $169,200.00 |
DisclosureSEC source: 0001567619-22-008245 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,853 Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:15 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 16,000 | $5.84 | $93,440.00 |
DisclosureSEC source: 0001567619-22-008245 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,853 Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:54 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 700 | $4.84 | $3,388.00 |
DisclosureSEC source: 0001567619-22-007864 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 316,972 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is a 93% shareholder. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:54 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 10,000 | $4.71 | $47,100.00 |
DisclosureSEC source: 0001567619-22-007864 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 316,272 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is a 93% shareholder. Read SEC document |
| March 29, 2022 Filed Apr 1, 2022 20:54 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 5,000 | $5.12 | $25,600.00 |
DisclosureSEC source: 0001567619-22-007864 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 306,272 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is a 93% shareholder. Read SEC document |
| March 21, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 10,000 | $4.35 | $43,500.00 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 8 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,853 Read SEC document |
| March 09, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 11,875 | $4.00 | $47,500.00 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 7 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,853 Read SEC document |
| March 08, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 8,125 | $4.00 | $32,500.00 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 6 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,978 Read SEC document |
| March 07, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 24,392 | $4.43 | $108,056.56 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 5 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,853 F4 · price: This transaction was executed in multiple trades at prices ranging from $3.97 to $4.53 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 04, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,800 | $5.51 | $20,938.00 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 301,272 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| March 03, 2022 Filed Mar 29, 2022 20:52 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 47,648 | $5.47 | $260,634.56 |
DisclosureSEC source: 0001567619-22-007664 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 297,472 F3 · price: This transaction was executed in multiple trades at prices ranging from $5.39 to $5.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.